Zebularine induces long-term survival of pancreatic islet allotransplants in streptozotocin treated diabetic rats.

Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

Abstract

Coping with the immune rejection of allotransplants or autologous cells in patients with an active sensitization towards their autoantigens and autoimmunity presently necessitates life-long immune suppressive therapy acting on the immune system as a whole, which makes the patients vulnerable to infections and increases their risk of developing cancer. New technologies to induce antigen selective long-lasting immunosuppression or immune tolerance are therefore much needed.

Detaljer

Författare
Enheter & grupper
Forskningsområden

Ämnesklassifikation (UKÄ) – OBLIGATORISK

  • Neurologi
  • Kirurgi
Originalspråkengelska
Artikelnummere71981
TidskriftPLoS ONE
Volym8
Utgåva nummer8
StatusPublished - 2013
PublikationskategoriForskning
Peer review utfördJa

Nedladdningar

Ingen tillgänglig data